EIA for the quantitative determination of phosphorylated Tau (Phospho-Tau(181P)) in human cerebrospinal fluid (CSF) – a diagnostic marker of Alzheimer’s disease
Quantitative assay for the simultaneous quantification of phosphorylated tau (P-tau(181P)), tau, and ß-amyloid(1-42) (Aß(1-42)) in human CSF using xMAP Luminex instrumentation
EIA for the quantitative determination of Tau protein in human cerebrospinal fluid (CSF). It measures the biomarker total Tau including 6 isoforms (352 to 441 amino acids - a...
Antibodies for use in Alzheimer's Disease pathology in-house assays
EIA for the quantitative determination of ß-amyloid(1-42) in human cerebrospinal fluid (CSF) - a diagnostic marker of Alzheimer's disease Alzheimer's, the most common form of...
